Legend Biotech Corporation (LEGN)

Nasdaq: LEGN · Pharmaceutical Preparations · Somerset, NJ · filing with the SEC since 2020

Grade6.1

◀ Past 6.9● Present 5.7▶ Future 5.8

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.

Income statement, by fiscal year, newest first
Fiscal year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Report filed	Mar 10, 2026	Mar 11, 2025	Mar 19, 2024	Mar 30, 2023	Mar 31, 2022	Apr 2, 2021	·	·
Revenue	1,028,900	627,300^r	285,100^r	50,328^r	68,826^r	75,000^r	59,980^r	49,133
Cost of revenue	397,100	216,400^r	144,200^r	65,363	0	0	·	·
Research and development	414,700	413,500^r	382,200^r	335,648	313,346	232,160	161,943	60,637
General and administrative	135,800	136,800^r	106,800^r	80,631	46,961^r	23,134^r	6,751^r	2,769
Operating income	-136,500	-309,500	-528,100	·	·	·	·	·
Finance costs	21,400	21,600^r	21,800^r	10,796	900	4,209	223	82
Finance income	40,100	61,200^r	54,500^r	8,182	971	2,930	4,581	6,214
Other gains and losses	-164,800	111,800^r	-24,800^r	1,345	317	113	1,058^r	·
Income before income taxes	-282,600	-158,100^r	-520,200^r	-445,724	-407,196^r	-308,285^r	-127,319^r	-1,616
Income tax expense	14,200	18,900^r	-1,900^r	625	-3,614^r	-41,912^r	-25,729^r	1,168
Net income	-296,800	-177,000^r	-518,300^r	-446,349	-403,582^r	-266,373^r	-101,590^r	-2,784
Net income to shareholders	·	-177,026	-518,254	-446,349	-403,582^r	-266,373^r	-101,590^r	-2,784
Net income to ordinary shareholders	·	-177,026	-518,254	-446,349	·	·	·	·
Earnings per share, basic	-0.81	-0.48	-1.47	-1.40	-1.43^r	-1.13^r	-0.51^r	-0.01
Earnings per share, diluted	-0.81	-0.48	-1.47	-1.40	-1.43^r	-1.13^r	-0.51^r	-0.01
Weighted average shares, basic	368,641,170	365,702,143	352,165,418	318,083,913	281,703,291	236,305,234	200,000,000	200,000,000
Weighted average shares, diluted	368,641,170	365,702,143	352,165,418	318,083,913	·	·	·	·

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it sold

ifrs-full:RevenueFromContractsWithCustomers
ifrs-full:Revenue

Cost of revenue what it cost to make or buy what it soldifrs-full:CostOfSales

Research and development spent on inventing what it sells nextifrs-full:ResearchAndDevelopmentExpense

General and administrative the cost of running the company itselfifrs-full:AdministrativeExpense

Operating income profit from running the business, before interest and taxifrs-full:ProfitLossFromOperatingActivities

Finance costs what its borrowing costifrs-full:FinanceCosts

Finance income what its cash and investments earnedifrs-full:FinanceIncome

Other gains and losses gains and costs outside the businessifrs-full:OtherGainsLosses

Income before income taxes profit before taxifrs-full:ProfitLossBeforeTax

Income tax expense tax charged on the period's profitifrs-full:IncomeTaxExpenseContinuingOperations

Net income the whole group's profit, minority holders' share includedifrs-full:ProfitLoss

Net income to shareholders the profit or loss that belongs to the company's shareholdersifrs-full:ProfitLossAttributableToOwnersOfParent

Net income to ordinary shareholders what is left for common shareholdersifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity

Earnings per share, basic net income per share outstandingifrs-full:BasicEarningsLossPerShare

Earnings per share, diluted net income per share, counting every share that could be issuedifrs-full:DilutedEarningsLossPerShare

Weighted average shares, basic the average count of shares outstandingifrs-full:WeightedAverageShares

Weighted average shares, diluted the average count with every share that could be issuedifrs-full:AdjustedWeightedAverageShares

SI Assistanton LEGN · research, not advice